International Consortium for MDS

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

International Consortium for MDS

Jan 4, 2025, 13:13 | Insight

Amer Zeidan: Reducing Clinical Trial Eligibility Barriers for Myelodysplastic Syndromes/Neoplasms

Amer Zeidan, Associate Professor of Medicine (Hematology) at Yale University, shared a post on X,…

Dec 19, 2024, 21:47 | Blog

Amer Zeidan: As 2024 winds down, I contemplate

Amer Zeidan, Associate Professor of Medicine (Hematology) at Yale University, shared a post on X:…

Jul 15, 2024, 07:30 | Blog

The international Consortium for MDS in Boston 2024

International Consortium for MDS (icMDS) shared post on X: . "The international Consortium for MDS…

Jul 15, 2024, 07:03 | Blog

Amer Zeidan: Our 2nd International Consortium for MDS

Amer Zeidan shared a post on X: . "Our 2nd International Consortium for MDS (icMDS)…

Jul 3, 2024, 18:25 | Blog

Amer Zeidan: Big data and quality of life measures to improve outcomes of MDS patients in iwMDS24 with talks from Spain

Amer Zeidan shared on X: "Mikkael A. Sekeres and Hetty Carraway moderating a great session about…

All: 5 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023